Technical Analysis for BTX - BioTime, Inc.

Grade Last Price % Change Price Change
grade C 1.57 -3.68% -0.06
BTX closed down 3.68 percent on Tuesday, March 19, 2019, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical BTX trend table...

Date Alert Name Type % Chg
Mar 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 19 Calm After Storm Range Contraction 0.00%
Mar 19 Upper Bollinger Band Walk Strength 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 19 Overbought Stochastic Strength 0.00%
Mar 18 Jack-in-the-Box Bullish Bullish Swing Setup -3.68%
Mar 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.68%
Mar 18 Calm After Storm Range Contraction -3.68%
Mar 18 Upper Bollinger Band Walk Strength -3.68%
Mar 18 Inside Day Range Contraction -3.68%

Older signals for BTX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
BioTime, Inc., a biotechnology company, focuses on regenerative medicine and blood plasma volume expanders. The company primarily focuses on regenerative medicine, which refers to therapies based on human embryonic stem cell and induced pluripotent stem cell technology designed to rebuild cell and tissue function lost due to degenerative disease or injury. It develops and markets research products in the field of stem cells, including an array of proprietary PureStem cell lines and associated ESpan culture media, HyStem hydrogels, and differentiation kits, as well as offers Hextend, a blood plasma volume expander. The company is developing Renevia, a biocompatible, implantable hyaluronan, and collagen-based matrix for cell delivery in human clinical applications; stem cell-based therapies for retinal and neural degenerative diseases; and therapies to treat orthopedic disorders, diseases, and injuries. It is also developing PanC-Dx, a non-invasive blood-based cancer screening test; and therapeutic products for cardiovascular and blood diseases and disorders. In addition, the company markets GeneCards, a human gene database. Further, it is developing an integrated database suite to complement GeneCards that would include the LifeMap database of embryonic development, stem cell research, and regenerative medicine, as well as MalaCards, the human disease database. BioTime, Inc. was founded in 1990 and is headquartered in Alameda, California.
Biotechnology Life Sciences Biology Diseases Stem Cells Emerging Technologies Disorders Regenerative Medicine Therapeutic Products Injury Degenerative Disease Induced Stem Cells Biotime Embryonic Stem Cell Human Disease Injuries Culture Media
Is BTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.81
52 Week Low 0.66
Average Volume 1,097,129
200-Day Moving Average 1.8511
50-Day Moving Average 1.2224
20-Day Moving Average 1.346
10-Day Moving Average 1.479
Average True Range 0.1463
ADX 25.79
+DI 22.0682
-DI 14.0123
Chandelier Exit (Long, 3 ATRs ) 1.2911
Chandelier Exit (Short, 3 ATRs ) 1.5589
Upper Bollinger Band 1.696
Lower Bollinger Band 0.996
Percent B (%b) 0.82
BandWidth 52.005944
MACD Line 0.1144
MACD Signal Line 0.0786
MACD Histogram 0.0359
Fundamentals Value
Market Cap 181.81 Million
Num Shares 116 Million
EPS 0.60
Price-to-Earnings (P/E) Ratio 2.62
Price-to-Sales 81.83
Price-to-Book 1.49
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.74
Resistance 3 (R3) 1.73 1.67 1.71
Resistance 2 (R2) 1.67 1.63 1.67 1.70
Resistance 1 (R1) 1.62 1.60 1.59 1.63 1.69
Pivot Point 1.56 1.56 1.55 1.56 1.56
Support 1 (S1) 1.51 1.52 1.48 1.52 1.45
Support 2 (S2) 1.45 1.49 1.45 1.44
Support 3 (S3) 1.40 1.45 1.43
Support 4 (S4) 1.41